<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36961448</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>210</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice.</ArticleTitle><Pagination><StartPage>1209</StartPage><EndPage>1221</EndPage><MedlinePgn>1209-1221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.2200818</ELocationID><Abstract><AbstractText>Autosomal recessive PRKCD deficiency has previously been associated with the development of systemic lupus erythematosus in human patients, but the mechanisms underlying autoimmunity remain poorly understood. We introduced the Prkcd G510S mutation that we previously associated to a Mendelian cause of systemic lupus erythematosus in the mouse genome, using CRISPR-Cas9 gene editing. PrkcdG510S/G510S mice recapitulated the human phenotype and had reduced lifespan. We demonstrate that this phenotype is linked to a B cell-autonomous role of Prkcd. A detailed analysis of B cell activation in PrkcdG510S/G510S mice shows an upregulation of the PI3K/mTOR pathway after the engagement of the BCR in these cells, leading to lymphoproliferation. Treatment of mice with rapamycin, an mTORC1 inhibitor, significantly improves autoimmune symptoms, demonstrating in&#xa0;vivo the deleterious effect of mTOR pathway activation in PrkcdG510S/G510S mice. Additional defects in PrkcdG510S/G510S mice include a decrease in peripheral mature NK cells that might contribute to the known susceptibility to viral infections of patients with PRKCD mutations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moreews</LastName><ForeName>Marion</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5116-2443</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathieu</LastName><ForeName>Anne-Laure</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-2893-7001</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pouxvielh</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuschl&#xe9;</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-5344-8066</Identifier><AffiliationInfo><Affiliation>INSERM UMR-S1109, Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases, Tertiary Center for Primary Immunodeficiency, Faculty of Pharmacy, Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drouillard</LastName><ForeName>Annabelle</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7188-7655</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dessay</LastName><ForeName>P&#xe9;n&#xe9;lope</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meignien</LastName><ForeName>Marie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5404-7555</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7392-8270</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallone</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousseaux</LastName><ForeName>No&#xeb;mi</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7152-1300</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainouze</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6928-932X</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rey</LastName><ForeName>Amaury</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6355-7119</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omarjee</LastName><ForeName>Ommar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decembre</LastName><ForeName>Elodie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenief</LastName><ForeName>Vanina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djebali</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0567-5387</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thaunat</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3648-8963</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lyon-Est Medical Faculty, Claude Bernard University (Lyon 1), Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreux</LastName><ForeName>Marl&#xe8;ne</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6607-4796</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genestier</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0527-4583</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defrance</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6943-358X</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soulas-Sprauel</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2058-4811</Identifier><AffiliationInfo><Affiliation>INSERM UMR-S1109, Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases, Tertiary Center for Primary Immunodeficiency, Faculty of Pharmacy, Universit&#xe9; de Strasbourg, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mar&#xe7;ais</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3591-6268</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walzer</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0857-8179</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belot</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4902-5332</Identifier><AffiliationInfo><Affiliation>CIRI, Centre International de Recherche en Infectiologie, (Team LYACTS), Univ Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospices Civils de Lyon, Edouard Herriot Hospital, Immunology Laboratory, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="Y">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36961448</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.2200818</ArticleId><ArticleId IdType="pii">263553</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>